Extragenital adenosarcoma: A case report, review of the literature, and management discussion

Gloria S. Huang, Rebecca C. Arend, Antoinette Sakaris, Tiffany M. Hebert, Gary L. Goldberg

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: Müllerian adenosarcoma is a rare mixed epithelial-mesenchymal tumor. An extragenital site of origin and sarcomatous overgrowth are associated with aggressive clinical behavior. Case: We present a rare case of extragenital adenosarcoma with sarcomatous overgrowth and coexistent endometriosis. She was treated with initial cytoreductive surgery and chemotherapy. She underwent a second surgery for management of a high-grade bowel obstruction, due to pathologically confirmed recurrent intraperitoneal adenosarcoma. A complete clinical response was achieved with liposomal doxorubicin, and the patient remains disease-free eighteen months after completion of chemotherapy. Conclusion: Liposomal doxorubicin appears to be an active agent for the treatment of adenosarcoma with sarcomatous overgrowth. In addition, we conclude from our review of all reported cases of extragenital adenosarcoma that concurrent endometriosis may represent a favorable prognostic factor.

Original languageEnglish (US)
Pages (from-to)472-475
Number of pages4
JournalGynecologic Oncology
Volume115
Issue number3
DOIs
StatePublished - Dec 2009

Fingerprint

Adenosarcoma
Endometriosis
Drug Therapy
Neoplasms

Keywords

  • Adenosarcoma
  • Chemotherapy
  • Endometriosis
  • Sarcoma

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Extragenital adenosarcoma : A case report, review of the literature, and management discussion. / Huang, Gloria S.; Arend, Rebecca C.; Sakaris, Antoinette; Hebert, Tiffany M.; Goldberg, Gary L.

In: Gynecologic Oncology, Vol. 115, No. 3, 12.2009, p. 472-475.

Research output: Contribution to journalArticle

Huang, Gloria S. ; Arend, Rebecca C. ; Sakaris, Antoinette ; Hebert, Tiffany M. ; Goldberg, Gary L. / Extragenital adenosarcoma : A case report, review of the literature, and management discussion. In: Gynecologic Oncology. 2009 ; Vol. 115, No. 3. pp. 472-475.
@article{5f3a2983da1e4994a54353a2ed03432a,
title = "Extragenital adenosarcoma: A case report, review of the literature, and management discussion",
abstract = "Background: M{\"u}llerian adenosarcoma is a rare mixed epithelial-mesenchymal tumor. An extragenital site of origin and sarcomatous overgrowth are associated with aggressive clinical behavior. Case: We present a rare case of extragenital adenosarcoma with sarcomatous overgrowth and coexistent endometriosis. She was treated with initial cytoreductive surgery and chemotherapy. She underwent a second surgery for management of a high-grade bowel obstruction, due to pathologically confirmed recurrent intraperitoneal adenosarcoma. A complete clinical response was achieved with liposomal doxorubicin, and the patient remains disease-free eighteen months after completion of chemotherapy. Conclusion: Liposomal doxorubicin appears to be an active agent for the treatment of adenosarcoma with sarcomatous overgrowth. In addition, we conclude from our review of all reported cases of extragenital adenosarcoma that concurrent endometriosis may represent a favorable prognostic factor.",
keywords = "Adenosarcoma, Chemotherapy, Endometriosis, Sarcoma",
author = "Huang, {Gloria S.} and Arend, {Rebecca C.} and Antoinette Sakaris and Hebert, {Tiffany M.} and Goldberg, {Gary L.}",
year = "2009",
month = "12",
doi = "10.1016/j.ygyno.2009.07.033",
language = "English (US)",
volume = "115",
pages = "472--475",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Extragenital adenosarcoma

T2 - A case report, review of the literature, and management discussion

AU - Huang, Gloria S.

AU - Arend, Rebecca C.

AU - Sakaris, Antoinette

AU - Hebert, Tiffany M.

AU - Goldberg, Gary L.

PY - 2009/12

Y1 - 2009/12

N2 - Background: Müllerian adenosarcoma is a rare mixed epithelial-mesenchymal tumor. An extragenital site of origin and sarcomatous overgrowth are associated with aggressive clinical behavior. Case: We present a rare case of extragenital adenosarcoma with sarcomatous overgrowth and coexistent endometriosis. She was treated with initial cytoreductive surgery and chemotherapy. She underwent a second surgery for management of a high-grade bowel obstruction, due to pathologically confirmed recurrent intraperitoneal adenosarcoma. A complete clinical response was achieved with liposomal doxorubicin, and the patient remains disease-free eighteen months after completion of chemotherapy. Conclusion: Liposomal doxorubicin appears to be an active agent for the treatment of adenosarcoma with sarcomatous overgrowth. In addition, we conclude from our review of all reported cases of extragenital adenosarcoma that concurrent endometriosis may represent a favorable prognostic factor.

AB - Background: Müllerian adenosarcoma is a rare mixed epithelial-mesenchymal tumor. An extragenital site of origin and sarcomatous overgrowth are associated with aggressive clinical behavior. Case: We present a rare case of extragenital adenosarcoma with sarcomatous overgrowth and coexistent endometriosis. She was treated with initial cytoreductive surgery and chemotherapy. She underwent a second surgery for management of a high-grade bowel obstruction, due to pathologically confirmed recurrent intraperitoneal adenosarcoma. A complete clinical response was achieved with liposomal doxorubicin, and the patient remains disease-free eighteen months after completion of chemotherapy. Conclusion: Liposomal doxorubicin appears to be an active agent for the treatment of adenosarcoma with sarcomatous overgrowth. In addition, we conclude from our review of all reported cases of extragenital adenosarcoma that concurrent endometriosis may represent a favorable prognostic factor.

KW - Adenosarcoma

KW - Chemotherapy

KW - Endometriosis

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=70350774060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350774060&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2009.07.033

DO - 10.1016/j.ygyno.2009.07.033

M3 - Article

C2 - 19712965

AN - SCOPUS:70350774060

VL - 115

SP - 472

EP - 475

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 3

ER -